0001140361-13-047323.txt : 20131223
0001140361-13-047323.hdr.sgml : 20131223
20131223140229
ACCESSION NUMBER: 0001140361-13-047323
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20131223
DATE AS OF CHANGE: 20131223
EFFECTIVENESS DATE: 20131223
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEM CELL THERAPEUTICS CORP
CENTRAL INDEX KEY: 0001392333
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-208615
FILM NUMBER: 131294190
BUSINESS ADDRESS:
STREET 1: 96 SKYWAY AVENUE
CITY: TORONTO
STATE: A6
ZIP: M9W 4Y9
BUSINESS PHONE: (416) 457-4670
MAIL ADDRESS:
STREET 1: 96 SKYWAY AVENUE
CITY: TORONTO
STATE: A6
ZIP: M9W 4Y9
D
1
primary_doc.xml
X0707
D
LIVE
0001392333
STEM CELL THERAPEUTICS CORP
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
416-457-4670
ONTARIO, CANADA
None
None
Corporation
true
Niclas
Stiernholm
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Executive Officer
Director
Robert
Uger
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Executive Officer
Penka
Petrova
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Executive Officer
James
Todd
Parsons
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Executive Officer
David
Geoffrey Peter
Allan
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
James
Michael
DeMesa
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
Henry
G.
Friesen
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
Michael
Moore
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
Ronald
Dean
Peterson
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
Calvin
Ralph
Stiller
96 Skyway Avenue
Toronto
A6
ONTARIO, CANADA
M9W 4Y9
Director
Biotechnology
Decline to Disclose
- 06b
false
2013-12-13
false
true
true
true
true
Offered Units = Units & Preferred Units; Units = 1 common share & 3/4 common share warrant; Preferred Units = 1 series I convertible preferred share & 3/4 common share warrant.
false
0
ROTH Capital Partners, LLC
15407
None
None
730 Fifth Ave., 25th Floor
New York
NY
NEW YORK
10019
CA
CALIFORNIA
CT
CONNECTICUT
MA
MASSACHUSETTS
NJ
NEW JERSEY
NY
NEW YORK
false
Bloom Burton & Co. Inc.
None
None
None
65 Front Street East, Suite 300
Toronto
A6
ONTARIO, CANADA
M5E 1B5
false
60697057
30298825
30398232
Aggregate offering includes amout that may be received by Issuer upon exercise of warrants. Each whole warrant may be exercised for one common share at an exercise price of CDN$0.28 per share for a period of 5 years after Closing.
false
22
1817929
0
In addition to cash commission, agents may also receive up to 5,014,839 options. Each option may be exercised for one common share at a price of CDN$0.21 per share for a period of 24 months from Closing.
0
false
STEM CELL THERAPEUTICS CORP
/s/ James T. Parsons
James T. Parsons
Chief Financial Officer
2013-12-17